Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.
Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results